BSECompany UpdateResults2d ago
Colinz Laboratories Ltd
Dear sir,
Please find the attached News Paper Publication as required under Regulation 47(3) of SEBI(LODR), 2015. for the Quarter and Half year ended on 30-9-2026. Kindly take the same on records.
For Colinz Labs Ltd
Director
Colinz Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported revenue of Rs. 168.91 crore and a net profit of Rs. 12.65 crore for the quarter, and Rs. 662.05 crore and Rs. 40.25 crore, respectively, for the half year. The earnings per share (EPS) for the quarter and half year were Rs. 0.50 and Rs. 2.04, respectively. The company's financial results have been reviewed by the audit committee and approved by the board of directors.
BSEResultResults3d ago
Colinz Laboratories Ltd
The Attached Results for Quarter ended on 30-9-2026 was approved in Bopard Meeting held on 29-10-2026 as required under Regulation 30 and 33 and our Auditors have issued Limited Review Report on the same.
Kindly take the same on records.
For Colinz Labs Ltd
Director
Colinz Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended 30th September 2026, which were approved by the Board of Directors in a meeting held on 29th October 2026. The results show a revenue from operations of Rs. 155.00 lakhs for the quarter and Rs. 279.09 lakhs for the half year, with a net profit of Rs. 12.65 lakhs for the quarter and Rs. 252.77 lakhs for the half year.
BSEBoard MeetingResults3d ago
Colinz Laboratories Ltd
We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 29th October, 2026 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and half year ended on 30th September, 2026.
Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 29th October, 2026 received from Vora & Associates, Chartered Accountants, Statutory Auditors ....
Colinz Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended on 30th September, 2026, with revenue from operations at Rs. 279.09 lakhs and profit before tax at Rs. 18.65 lakhs.
BSEBoard MeetingResults19 Oct 2026
Colinz Laboratories Ltd
Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve We wish to inform you that pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), a meeting of the Board of Directors of the Company is scheduled ....
Colinz Laboratories Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 29/10/2026 to consider and approve unaudited financial results for the quarter and half year ended on September 30, 2026.
BSECompany UpdateResults7 Oct 2026
Colinz Laboratories Ltd
Dear Sir,
PFA, The Compliance Certificate issued by our RTA for Sep-26 under regulation 74(5). Kindly take the same on records .
For Colinz Labs Ltd
Director
Colinz Laboratories Ltd has issued a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
BSECompany Update1 Oct 2026
Colinz Laboratories Ltd
Dear Sir,
PFA, attached Certificate under Regulation 32 of SEBI(LODR) Regulation,2015 and Statement of Deviation or Variation is NOT applicable to the Company for the Quarter Ended on 30-9-2026. Kindly take the same on records.
For Colinz Labs Ltd
Director
Colinz Laboratories Ltd has informed BSE that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company for the quarter ended 30.09.2026, as no public issue, rights issue, preferential issue, or QIP was made during this period.
BSECompany UpdateRelated Party1 Oct 2026
Colinz Laboratories Ltd
Dear Sir,
Pursuant to Regulations23(9) of SEBI (LODR). Regulations,2015, the said Regulation is not applicable to us, Kindly take the Non-Applicability Certificate on records for Quarter Ending on 30-9-2026.
FOr Colinz Labs Ltd
Director
01-10-2026
Colinz Laboratories Ltd has declared that it is not required to submit related party transaction disclosures for the quarter ended 30th September 2026, citing exemption under Regulation 15(2)(a) of SEBI (LODR) Regulations, 2015.
BSEInsider Trading / SAST29 Sept 2026
Colinz Laboratories Ltd
We would like to inform you that pursuant to the COmpanys Act and SEBI(PIT), Regulation, 2015 The Trading Window for Designated Persons and KMPS will remain closed form 1-10-26 to till 48 hours after the announcement of Financial Results for the Quarter ended 30-9-2026. Kindly take the same on records.
for Colinz Labs Ltd
Vijaya Mani
Colinz Laboratories Ltd has announced the closure of its trading window for designated persons from October 1, 2026, until 48 hours after the announcement of its financial results for the quarter ended September 30, 2026.
BSEAGM/EGMResults23 Sept 2026
Colinz Laboratories Ltd
Please find enclosed herewith the Srutinizers Report for our 40th AGM held on 22-09-2026 issued todted dated 23-09-2026. Kindly take the same on records.
For Colinz Labs Ltd
Director
Colinz Laboratories Ltd has announced the results of its 40th AGM, where all resolutions were approved with the requisite majority. The company had provided remote e-voting and electronic voting facilities to its shareholders.
BSEAGM/EGMMgmt Change22 Sept 2026
Colinz Laboratories Ltd
DEAR SIR
SUMMERY OF OF 40TH AGM HELD ON 22-09-2026 AT 2.30 PM . KINDLY TAKE THE SAME ON RECORDS
FOR COLINZ LABORATORIES LTD
VIJAYA MANI
CHAIRPESRSON OF THE MEETING
Colinz Laboratories Ltd held its 40th Annual General Meeting (AGM) on September 22, 2026, through video conferencing. The meeting approved the audited financial statements for the year ended March 31, 2026, and reappointed Mr. N. K. Menon as Whole Time Director & Chief Executive Officer. The company also extended remote e-voting facilities to its members.
BSECompany UpdateResults27 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
Pursuant to Regualtion 47 of SEBI(LODR) Regulations, 2015 we ahereby enclosed News Papar Cliping of our 40 th AGM Ads given in the Paper on 27-08-2026. Kindly take the same ....
Colinz Laboratories Ltd has announced the notice of its 40th Annual General Meeting (AGM) through video conference, book closure, and e-voting. The meeting will be held on September 27, 2026, and the register of members and share transfer books will remain closed from September 15 to 22, 2026.
BSEOthersResults20 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....
Colinz Laboratories Ltd has announced its 40th Annual Report for FY 2025-26, along with the reappointment of directors and other business resolutions.
BSECorp. ActionResults20 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
AS requied under Regulation 42 of SEBI(LODR) , Regulations, 2015 we are submitting herewith the Intimation towards closure of Book from 15-09-2026 to 22-09-2026 for the purpose ....
Colinz Laboratories Ltd has announced the closure of its book from September 15, 2026, to September 22, 2026, for the purpose of its 40th Annual General Meeting (AGM). The company will provide a facility for its members to cast their votes through remote e-voting starting from September 19, 2026, to September 21, 2026. The cut-off date for determining the list of shareholders who may cast their votes electronically is September 15, 2026.
BSEAGM/EGMMgmt Change20 Aug 2026
Colinz Laboratories Ltd
As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submitting herewith 40th AGM Notice of our ....
Colinz Laboratories Ltd has announced the notice of its 40th Annual General Meeting (AGM) and book closure, where the company will consider and adopt the audited financial statements for the financial year ended March 31, 2026, and re-appoint Mr. N. K. Menon as a Director and Whole-Time Director & Chief Executive Officer, and consider the re-appointment of Mr. Menon on terms and conditions.
BSECompany UpdateFundraise12 Aug 2026
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation to the open offer of Colinz Laboratories ....
Colinz Laboratories Ltd has received an open offer from Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 26% of the company's voting share capital for ₹3,53,68,164.
BSECompany UpdateFundraise6 Aug 2026
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, ....
Colinz Laboratories Ltd has received an open offer from Saffron Capital Advisors Pvt Ltd on behalf of Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 6,54,966 shares, representing 26% of the company's voting share capital, at ₹54 per share.
BSECompany UpdateRelated Party5 Aug 2026
Colinz Laboratories Ltd
Dear Sir,
Submitting herewith the News Paper Clipping towards Advertiement in Newspaper towards submission of Declaration of Independent Directors Under SEBI SAST Regulation ,2011 and ....
Colinz Laboratories Ltd has announced an open offer by Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 6,54,966 equity shares of the company at Rs. 54 per share, representing 26.7% of the voting share capital, under the SEBI (SAST) Regulations, 2011.
BSECompany UpdateFundraise31 Jul 2026
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....
Colinz Laboratories Ltd has received an open offer from Saffron Capital Advisors Pvt Ltd on behalf of Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 26% of the company's voting share capital for ₹ 54 per share.
BSECompany UpdateResults31 Jul 2026
Colinz Laboratories Ltd
Dear Sir,
As required under SEBI(LODR), Regulation, 2015, we are submitting herewith the News Paper Publication , published on 31-7-2026 for the Quarter Ended 30-6-2026. Kindly take ....
Colinz Laboratories Ltd has submitted its audited financial results for the quarter ended June 30, 2026, as required under SEBI (LODR) Regulation, 2015. The results show revenue from operations of Rs. 136.26 crore, net profit of Rs. 290.12 crore, and earnings per share of Rs. 9.53.
BSEResultResults30 Jul 2026
Colinz Laboratories Ltd
Please find the attached OUTCOME of the meeting held today dated 30-07-2026 the details of the approved agenda are shown in the OUTCOME.
Colinz Laboratories Ltd held its board meeting on July 30, 2026, and approved several items, including unaudited financial results for the quarter ended June 30, 2026, director's report, management discussion report, corporate governance report, and the appointment of new directors and auditors.